Established in April 1993 by Dr. Alex Kozak, D-Pharm is a specialty pharmaceutical company that designs and develops innovative drugs for the treatment of the most devastating brain disorders. The Company has developed two unique platform technologies that generate lipid–like medicines which ...

more

Powered with strategic vision and financial vigor, Clal Biotechnology Industries (CBI) Ltd is one of the largest biotechnology investment entities in Israel. CBI targets promising companies with innovative bio-pharma technologies and transforms them into thriving, productive businesses. ...

more

CollPlant Ltd. specializes in the development and commercialization of medical products based on safe, plant-derived collagen and other recombinant proteins produced in its proprietary transgenic plant expression and production system.

more

Founded in 2001, Allium Ltd., is a privately owned company initiated and led by Professor (Em.) Daniel Yachia, an acknowledged urologist and international authority on Urinary System Stenting. Allium has developed a multi-patented technology platform for creating site-specific stent ...

more

Kamada is a public biopharmaceutical company developing, producing and marketing a line of specialty life-saving biopharmaceuticals using its proprietary chromatographic purification technologies. Licensed and marketed worldwide, several of these specialty therapeutics are currently ...

more

Pluristem Therapeutics Inc. is a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products, derived from human placenta, for the treatment of several severe ischemic and autoimmune disorders.

more

NasVax engages in the development of improved vaccines. Its technology platform is based on proprietary polycationic sphingolipid-derived molecules that serve both as a potent adjuvant for stimulating enhanced immune responses via the Th1 and Th2 pathways as well as an efficient delivery ...

more

BioLineRx, a clinical stage drug development company traded on the Tel Aviv Stock Exchange, is dedicated to building a robust pipeline of promising therapeutics for unmet medical needs. The Company’s leading programs are for schizophrenia and treatment of damaged heart tissue post-myocardial ...

more

Polyheal Ltd., a subsidiary of Clal Biotechnology Industries Ltd. (TASE: CBI) has developed a technology for treating hard to heal wounds, such as wounds caused by Diabetes, Cardiovascular disease and Post trauma and Post surgical wounds, which until now do not have effective treatments that ...

more

Zetiq Technologies Ltd. develops effective cancer diagnostic tools. There is a significant medical need for early stage diagnostic tools for screening, monitoring or diagnosing cancer. Zetiq offers unique advantages in this market with its proprietary CellDetect® technology for differential ...

more